Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Lung Cancer

  Free Subscription


18.03.2024

1 AJR Am J Roentgenol
1 Am J Ind Med
1 Ann Surg Oncol
1 Arch Bronconeumol
3 BMC Cancer
1 Cancer
2 Cancer Cell
1 Carcinogenesis
4 Chest
1 Clin Exp Metastasis
1 Clin Lung Cancer
1 Eur J Cancer
1 Eur J Cardiothorac Surg
1 Int J Cancer
2 J Cancer Res Clin Oncol
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Nucl Med
2 J Thorac Cardiovasc Surg
10 J Thorac Oncol
1 Lancet Oncol
1 Lung Cancer
1 Oncogene
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. TAILOR TD, Christensen JD
    Beyond the AJR: Potential Role for Opportunistic Lung Cancer Screening.
    AJR Am J Roentgenol. 2024 Mar 13. doi: 10.2214/AJR.24.31039.
    PubMed        


    Am J Ind Med

  2. ALEXANDER BH, Ryan A, Church TR, Kim H, et al
    Mortality and cancer incidence in perfluorooctanesulfonyl fluoride production workers.
    Am J Ind Med. 2024;67:321-333.
    PubMed         Abstract available


    Ann Surg Oncol

  3. PARK S, Choe J, Lee SM, Choi S, et al
    ASO Visual Abstract: Surgical Outcomes in Non-small Cell Lung Cancer with Distant Metastasis: The Prognostic Significance of Delayed Metastasis Diagnosis.
    Ann Surg Oncol. 2024 Mar 14. doi: 10.1245/s10434-024-15135.
    PubMed        


    Arch Bronconeumol

  4. SARDELLA L, Merlo E, Casutt A
    Endobronchial High-Grade Non-Hodgkin B-Cell Lymphoma Mimicking Small Cell Lung Cancer.
    Arch Bronconeumol. 2024 Feb 24:S0300-2896(24)00052.
    PubMed        


    BMC Cancer

  5. KAHM YJ, Kim IG, Kim RK
    Regulation of cancer stem cells by CXCL1, a chemokine whose secretion is controlled by MCM2.
    BMC Cancer. 2024;24:319.
    PubMed         Abstract available

  6. WANG S, Oliveira-Silveira J, Fang G, Kang J, et al
    High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line.
    BMC Cancer. 2024;24:335.
    PubMed         Abstract available

  7. PAN J, Wang J, Tao W, Wang C, et al
    Is low-dose computed tomography for lung cancer screening conveniently accessible in China? A spatial analysis based on cross-sectional survey.
    BMC Cancer. 2024;24:342.
    PubMed         Abstract available


    Cancer

  8. CITTOLIN-SANTOS GF, Knapp B, Ganesh B, Gao F, et al
    The changing landscape of small cell lung cancer.
    Cancer. 2024 Mar 12. doi: 10.1002/cncr.35281.
    PubMed         Abstract available


    Cancer Cell

  9. HU F, Lito P
    Insights into how adeno-squamous transition drives KRAS inhibitor resistance.
    Cancer Cell. 2024;42:330-332.
    PubMed         Abstract available

  10. HE XY, Gao Y, Ng D, Michalopoulou E, et al
    Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment.
    Cancer Cell. 2024;42:474-486.
    PubMed         Abstract available


    Carcinogenesis

  11. VISONA SD, Bertoglio B, Capella S, Belluso E, et al
    Asbestos burden in lungs of mesothelioma patients with pleural plaques, lung fibrosis and/or ferruginous bodies at histology: a postmortem SEM-EDS study.
    Carcinogenesis. 2024;45:131-139.
    PubMed         Abstract available


    Chest

  12. OST DE
    Development and Revision of Meaningful Stage Descriptors for M1a Non-Small Cell Lung Cancer.
    Chest. 2024;165:490-491.
    PubMed        

  13. MELZER AC, Begnaud A
    Planting the Seeds for Lung Cancer Screening Starts With Knowledge Holders.
    Chest. 2024;165:488-489.
    PubMed        

  14. CHRISTENSEN J, Prosper AE, Wu CC, Chung J, et al
    ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.
    Chest. 2024;165:738-753.
    PubMed         Abstract available

  15. LIAO Z, Wang H, An J, Dong J, et al
    A 49-Year-Old Man With Fever and Dyspnea After Endobronchial Ultrasound-Guided Transbronchial Fine Needle Aspiration Biopsy.
    Chest. 2024;165:e65-e69.
    PubMed         Abstract available


    Clin Exp Metastasis

  16. OKUNO T, Isobe T, Tsubata Y
    Current pharmacologic treatment of brain metastasis in non-small cell lung cancer.
    Clin Exp Metastasis. 2024 Mar 11. doi: 10.1007/s10585-024-10276.
    PubMed         Abstract available


    Clin Lung Cancer

  17. D'AIELLO A, Stiles B, Ohri N, Levy B, et al
    Perioperative Immunotherapy for Non-Small Cell Lung Cancer: Practical Application of Emerging Data and New Challenges.
    Clin Lung Cancer. 2024 Feb 13:S1525-7304(24)00015.
    PubMed         Abstract available


    Eur J Cancer

  18. KATSUMATA S, Shimokawa M, Hamada A, Haratake N, et al
    Impact of central nervous system metastasis after complete resection of lung adenocarcinomas harboring common EGFR mutation - A real-world database study in Japan: The CReGYT-01 EGFR study.
    Eur J Cancer. 2024;201:113951.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  19. MIURA K, Ide S, Minamisawa M, Mishima S, et al
    Sublobar resection or lobectomy and postoperative respiratory complications in emphysematous lungs.
    Eur J Cardiothorac Surg. 2024;65:ezae061.
    PubMed         Abstract available


    Int J Cancer

  20. KOURO T, Higashijima N, Horaguchi S, Mano Y, et al
    Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.
    Int J Cancer. 2024;154:1828-1841.
    PubMed         Abstract available


    J Cancer Res Clin Oncol

  21. SHIJUBOU N, Sumi T, Kubo T, Sasaki K, et al
    Prognostic significance of immunohistochemical classification utilizing biopsy specimens in patients with extensive-disease small-cell lung cancer treated with first-line chemotherapy and immune checkpoint inhibitors.
    J Cancer Res Clin Oncol. 2024;150:125.
    PubMed         Abstract available

  22. JU W, Lin L, Zhang Q, Lv X, et al
    GATA6 inhibits the biological function of non-small cell lung cancer by modulating glucose metabolism.
    J Cancer Res Clin Oncol. 2024;150:126.
    PubMed         Abstract available


    J Clin Oncol

  23. RODRIGUEZ GM, Popat R, Rosas LG, Patel MI, et al
    Racial and Ethnic Disparities in Intensity of Care at the End of Life for Patients With Lung Cancer: A 13-Year Population-Based Study.
    J Clin Oncol. 2024 Mar 13:JCO2301045. doi: 10.1200/JCO.23.01045.
    PubMed         Abstract available


    J Natl Cancer Inst

  24. NAGASAKI Y, Taki T, Nomura K, Tane K, et al
    Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non-small cell lung cancer.
    J Natl Cancer Inst. 2024 Mar 8:djae053. doi: 10.1093.
    PubMed         Abstract available


    J Nucl Med

  25. THOR M, Lee C, Sun L, Patel P, et al
    An (18)F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.
    J Nucl Med. 2024 Mar 14:jnumed.123.266965. doi: 10.2967/jnumed.123.266965.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  26. KIM AT, Ding L, Lee HB, Ashbrook MJ, et al
    Longer hospitalizations, more complications, and greater readmissions for patients with comorbid psychiatric disorders undergoing pulmonary lobectomy.
    J Thorac Cardiovasc Surg. 2024;167:1502-1511.
    PubMed         Abstract available

  27. ODEH AM, Perez-Tamayo RA, Abdelsattar ZM
    A wedge is still better than stereotactic body radiation therapy in the national cancer database.
    J Thorac Cardiovasc Surg. 2024;167:e100-e101.
    PubMed        


    J Thorac Oncol

  28. YANG SR, Gedvilaite E, Ptashkin R, Chang J, et al
    Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation.
    J Thorac Oncol. 2024;19:409-424.
    PubMed         Abstract available

  29. BORCZUK AC
    Invasive Size in Lung Adenocarcinoma-Reproducible Criteria, More Accurate Staging.
    J Thorac Oncol. 2024;19:360-362.
    PubMed        

  30. CANI M, Novello S, Bironzo P
    Mismatch Repair Deficiency in Lung Tumors: Adding a New Layer of Complexity on Pie Slices.
    J Thorac Oncol. 2024;19:363-365.
    PubMed        

  31. DAMMEIJER F, Dumoulin DW, Aerts JGJV
    Anti-Vascular Endothelial Growth Factor/Programmed Cell Death Protein 1 Bispecific Antibodies: Using Nunchucks to Fight an Old Adversary.
    J Thorac Oncol. 2024;19:366-369.
    PubMed        

  32. YALAMANCHALI A, Hassan KA
    MUC1-C: The Occam Razor of Osimertinib Resistance?
    J Thorac Oncol. 2024;19:370-372.
    PubMed        

  33. LIM SM, Lee JB, Cho BC
    Chemotherapy and Osimertinib Combination Should Not Be the First-Line Treatment for All Advanced EGFR+ NSCLC.
    J Thorac Oncol. 2024;19:376-379.
    PubMed        

  34. CHEN LN, Lee ATM, Nagasaka M, Ou SI, et al
    Chemotherapy and Osimertinib Combination Should Be the First-Line Treatment for All Advanced EGFR+ NSCLC.
    J Thorac Oncol. 2024;19:380-384.
    PubMed        

  35. LI CP, Tsai RY, Chang HC, Gau SY, et al
    Survival and Prognosis After Carbon-Ion Radiotherapy in Patients With NSCLC.
    J Thorac Oncol. 2024;19:507-508.
    PubMed        

  36. CHENG Y, Fan Y, Zhao Y, Huang D, et al
    Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (RATIONALE-312): a Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial
    J Thorac Oncol. 2024 Mar 7:S1556-0864(24)00115.
    PubMed         Abstract available

  37. HINES JB, Cameron RB, Esposito A, Kim L, et al
    Evaluation of MPR and pCR as surrogate endpoints for survival in randomized controlled trials of neoadjuvant immune checkpoint blockade in resectable in non-small cell lung cancer.
    J Thorac Oncol. 2024 Mar 8:S1556-0864(24)00117.
    PubMed         Abstract available


    Lancet Oncol

  38. GOULART BHL, Mushti SL, Chatterjee S, Larkins E, et al
    Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis.
    Lancet Oncol. 2024 Mar 5:S1470-2045(24)00040.
    PubMed         Abstract available


    Lung Cancer

  39. KIM DW, Chul Cho B, Pachipala K, Kim SW, et al
    Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
    Lung Cancer. 2024;190:107530.
    PubMed         Abstract available


    Oncogene

  40. KUMAR V, Yochum ZA, Devadassan P, Huang EH, et al
    TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer.
    Oncogene. 2024 Mar 1. doi: 10.1038/s41388-024-02987.
    PubMed         Abstract available


    PLoS One

  41. AHMAD A, Kulachi MO, Farman M, Junjua MU, et al
    Mathematical modeling and control of lung cancer with IL2 cytokine and anti-PD-L1 inhibitor effects for low immune individuals.
    PLoS One. 2024;19:e0299560.
    PubMed         Abstract available

  42. LEE YJ, Kang N, Nam J, Lee EG, et al
    The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.
    PLoS One. 2024;19:e0299484.
    PubMed         Abstract available

  43. MALIK H, Anees T
    Multi-modal deep learning methods for classification of chest diseases using different medical imaging and cough sounds.
    PLoS One. 2024;19:e0296352.
    PubMed         Abstract available

  44. XUE Y, Zhang D, Jia L, Yang W, et al
    Integrating image and gene-data with a semi-supervised attention model for prediction of KRAS gene mutation status in non-small cell lung cancer.
    PLoS One. 2024;19:e0297331.
    PubMed         Abstract available

  45. MAJUMDER S, Gautam N, Basu A, Sau A, et al
    MENet: A Mitscherlich function based ensemble of CNN models to classify lung cancer using CT scans.
    PLoS One. 2024;19:e0298527.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.